SEC Filings

Filing date	Form	Description	View
02/13/18	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001140361-18-007142.pdf 0001140361-18-007142.rtf 0001140361-18-007142.xls
02/13/18	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001213900-18-001706.pdf 0001213900-18-001706.rtf 0001213900-18-001706.xls
02/13/18	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001213900-18-001715.pdf 0001213900-18-001715.rtf 0001213900-18-001715.xls
02/09/18	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-18-007722.pdf 0001104659-18-007722.rtf 0001104659-18-007722.xls
02/08/18	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000932471-18-002756.pdf 0000932471-18-002756.rtf
02/07/18	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-18-007013.pdf 0001104659-18-007013.rtf 0001104659-18-007013.xls
01/30/18	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000215457-18-004142.pdf 0000215457-18-004142.rtf
01/08/18	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-18-001132.pdf 0001104659-18-001132.rtf 0001104659-18-001132.xls
01/03/18	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-18-000312.pdf 0001104659-18-000312.rtf 0001104659-18-000312.xls
12/07/17	CT ORDER	CT ORDER	View HTML 9999999997-17-010406.pdf

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools